This content is machine translated GLP-1-RA in type 2 diabetes Broad spectrum of action – weight reduction is also supported GLP-1 receptor agonists promote insulin secretion from pancreatic beta cells, leading to decreased glucose release by the liver and increasing insulin sensitivity. Moreover, they slow down gastric emptying and thus…
View Post 4 min This content is machine translated SUSTAIN-10: Post-hoc analysis Semaglutide and liraglutide in type 2 diabetes: effective and safe with and without SGLT-2-i Based on empirical evidence, professional societies recommend early combination of metformin with an SGLT-2 inhibitor or a GLP-1 receptor agonist in type 2 diabetics. Increasingly, a combined application of the…
View Post 4 min This content is machine translated Type 2 diabetes “Swiss Diabetes Guide” – digital tool supports physicians in drug selection The treatment options for type 2 diabetes mellitus are very complex. In addition to the large number of new active ingredients on the market, the scientific data base is constantly…
View Post 11 min This content is machine translated Role of incretin-based therapy GLP-1-RA and DPP-4 inhibitors in the management of type 2 diabetes. Insulin secretion by pancreatic beta cells is primarily influenced by glucose levels in the portal vein. In addition, secretion is also modulated by the so-called incretins. After food intake, they…
View Post 4 min This content is machine translated GLP-1 receptor agonists Jack of all trades in the fight against type 2 diabetes GLP-1 receptor agonists (RA) have been used in the treatment of diabetic patients since 2005. For patients, their introduction was a milestone, as GLP-1 RAs have the great advantage of…
View Post 13 min This content is machine translated Type 2 diabetes Focus on heart & kidney: therapy choice in patients with limiting factors Classes of drugs with different mechanisms of action are available for the treatment of type 2 diabetes. However, the presence of renal or cardiac insufficiency, cardiovascular disease, or insulin deficiency…
